The SAM Project: Science Against Malnutrition Project

Sponsor
Federico II University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06152848
Collaborator
(none)
2,000
1
36
55.5

Study Details

Study Description

Brief Summary

The latest data from the World Health Organization (WHO) shows that malnutrition in all its forms affects over 2.5 billion people globally. This condition is constantly increasing and affects the entire population, from childhood to the elderly. Malnutrition in all its forms negatively impacts the quality of life of patients affected and increases the risk of morbidity and mortality, as well as healthcare costs. Considering the complexity and multifactorial nature of malnutrition, the integration of multi-omics data obtained from analyzes with high-throughput technologies such as epigenomics, metagenomics, metabolomics, could benefit the prediction and evaluation of prognosis and/or response to specific treatments; this could pave the way for personalized precision medicine interventions for patients suffering from malnutrition. The SAM study aims to characterize malnutrition through the identification of specific biomarkers of the condition with the aim of developing innovative prevention and treatment programs.

Condition or Disease Intervention/Treatment Phase
  • Other: Data and samples collection

Study Design

Study Type:
Observational
Anticipated Enrollment :
2000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The SAM Project: Science Against Malnutrition Project
Actual Study Start Date :
Jul 24, 2023
Anticipated Primary Completion Date :
Jul 24, 2026
Anticipated Study Completion Date :
Jul 24, 2026

Arms and Interventions

Arm Intervention/Treatment
Patients affected by malnutrition

Patients affected by malnutrition due to deficiency or excess

Other: Data and samples collection
Collection of clinical, anamnestic and lifestyle data; collection of faecal, blood and saliva samples

Sex- and age- matched healthy controls

Sex- and age- matched healthy controls not affected by any pathology and/or malnutrition due to deficiency or excess

Other: Data and samples collection
Collection of clinical, anamnestic and lifestyle data; collection of faecal, blood and saliva samples

Outcome Measures

Primary Outcome Measures

  1. Characterization of malnutrition through the identification of specific biomarkers of the condition. [36 months]

    Data and samples analyses

  2. Untargeted microRNA expression profile in blood samples [36 months]

    TruSeq Small RNA Sample Preparation Kit (Illumina)

  3. Plasmatic extracellular vesicles [36 months]

    A transmission electron microscope will be used to analyze the morphology of extracellular vesicles and the total protein concentration of the extracellular vesicles will be measured with a Bradford assay and the quantitation of specific membrane proteins and specific intracellular proteins (Heat-Shock Proteins/HSP) will be carried out by ELISA.

  4. Metagenomic analysis of fecal samples [36 months]

    Shotgun analysis

  5. Metabolomicanalysis of fecal samples [36 months]

    Gas chromatography-mass spectrometry

  6. Untargeted microRNA expression profile in saliva samples [36 months]

    TruSeq Small RNA Sample Preparation Kit (Illumina)

  7. Salivary extracellular vesicles [36 months]

    A transmission electron microscope will be used to analyze the morphology of extracellular vesicles and the total protein concentration of the extracellular vesicles will be measured with a Bradford assay and the quantitation of specific membrane proteins and specific intracellular proteins (Heat-Shock Proteins/HSP) will be carried out by ELISA.

  8. Metagenomic analysis of salivary samples [36 months]

    Shotgun analysis

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Caucasian ethnicity;

  • both sexes;

  • age between 0 and 85 years;

  • affected by malnutrition due to deficiency or excess in association with other patology and sex- and age-matched healthy controls not affected by malnutrition due to deficiency or excess and any pathology

  • Written informed consent

Exclusion Criteria:
  • Non-Caucasian ethnicity;

  • Age > 85 years.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Traslational Medical Science - University of Naples Federico II Naples Italy 80131

Sponsors and Collaborators

  • Federico II University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roberto Berni Canani, MD, PhD, Medical Doctor, PhD, Professor, Federico II University
ClinicalTrials.gov Identifier:
NCT06152848
Other Study ID Numbers:
  • 2/2023
First Posted:
Dec 1, 2023
Last Update Posted:
Dec 1, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2023